Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Brain Metastases”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05893225
What this trial is testing

Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration

Who this might be right for
Multiple SclerosisPrimary Progressive Multiple SclerosisSecondary-progressive Multiple Sclerosis
University Hospital, Antwerp 120
Testing effectiveness (Phase 2)Study completedNCT01056471
What this trial is testing

Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis

Who this might be right for
Autoimmune DiseasesImmune System DiseasesDemyelinating Diseases+3 more
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 30
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Testing effectiveness (Phase 2)Ended earlyNCT02166658
What this trial is testing

Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)

Who this might be right for
Breast CancerLung CancerRecurrent Brain Metastases+1 more
AIO-Studien-gGmbH 8
Early research (Phase 1)Study completedNCT02423525
What this trial is testing

Safety Study of Afatinib for Brain Cancer

Who this might be right for
Brain Cancer
Santosh Kesari 24
Early research (Phase 1)Study completedNCT00614978
What this trial is testing

Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer

Who this might be right for
Metastatic Breast CancerBrain MetastasesHER2 Positive
Jules Bordet Institute 18
Testing effectiveness (Phase 2)UnknownNCT01144117
What this trial is testing

The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (Primary or Secondary Progressive Phase).
Rigshospitalet, Denmark 56
Testing effectiveness (Phase 2)Looking for participantsNCT05700721
What this trial is testing

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

Who this might be right for
Brain Metastases
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT00066248
What this trial is testing

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Who this might be right for
Brain TumorCentral Nervous System TumorsCachexia+5 more
University of South Florida 70
Early research (Phase 1)Study completedNCT00031928
What this trial is testing

Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 3,000
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT05866432
What this trial is testing

Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases

Who this might be right for
Breast Cancer Stage IV
Medical University of Vienna 20
Testing effectiveness (Phase 2)Study completedNCT00003062
What this trial is testing

Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 70
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Looking for participantsNCT06048718
What this trial is testing

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

Who this might be right for
Breast CancerMetastatic Breast Cancer
MedSIR 27
Large-scale testing (Phase 3)Study completedNCT00799890
What this trial is testing

Sunphenon in Progressive Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Friedemann Paul 61
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT01910259
What this trial is testing

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

Who this might be right for
Secondary Progressive Multiple Sclerosis
University College, London 445
Testing effectiveness (Phase 2)Study completedNCT01441596
What this trial is testing

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Boehringer Ingelheim 121
Large-scale testing (Phase 3)Active Not RecruitingNCT04674683
What this trial is testing

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

Who this might be right for
Unresectable or Metastatic MelanomaProgressive Brain Metastasis
HUYABIO International, LLC. 450
Load More Results